{"id":"NCT00578331","sponsor":"Alcon Research","briefTitle":"Safety Study of Olopatadine Nasal Spray","officialTitle":"Safety Study of Olopatadine Nasal Spray","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-12","primaryCompletion":"2008-01","completion":"2008-01","firstPosted":"2007-12-21","resultsPosted":"2010-02-03","lastUpdate":"2017-10-31"},"enrollment":890,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Perennial Allergic Rhinitis"],"interventions":[{"type":"DRUG","name":"Olopatadine 0.6% nasal spray","otherNames":[]},{"type":"DRUG","name":"Placebo Nasal Spray","otherNames":[]}],"arms":[{"label":"Olopatadine 0.6% Nasal Spray","type":"EXPERIMENTAL"},{"label":"Placebo Nasal Spray","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether olopatadine nasal spray is safe and effective when used for up to one year by patients with perennial allergic rhinitis.","primaryOutcome":{"measure":"Mean Response at Day 30 to the Patient-rated Relief Assessment Questionnaire","timeFrame":"day 30","effectByArm":[{"arm":"Placebo Nasal Spray","deltaMin":2.7,"sd":0.9},{"arm":"Olopatadine 0.6% Nasal Spray","deltaMin":2.5,"sd":0.9}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":445},"commonTop":["Epistaxis","Rhinitis","Upper respiratory tract infection","Nasopharyngitis","Sinusitis"]}}